Candriam Equities L Biotechnology Class C USD Cap

Register to Unlock Ratings
Management
DomicileLuxembourg
Legal StructureSICAV
UCITSYes
Inception Date06/04/2000
Fund Advisor(s)
Candriam
Fund ManagerLinden Thomson
Manager Start Date29/02/2024
Fund ManagerRudi Van den Eynde
Manager Start Date06/04/2000
Career Start Year1987
 
Biography
Due to European regulatory GDPR guidelines, Candriam cannot provide personal details as education or professional background to databases outside Europe. Information available on request only.
Fund ManagerServaas Michielssens
Manager Start Date30/04/2024
 
Biography
Servaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018. He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder.
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures